Abstract. GH binding to its receptor, which belongs to the cytokine receptor superfamily, activates Janus kinase (JAK) 2 tyrosine kinase, thereby activating a number of intracellular key proteins such as STAT (signal transducers and activators of transcription) proteins and mitogen-activated protein (MAP) kinases, which finally lead to GH's biological actions including gene expression. In contrast to receptor tyrosine kinases, the signalling pathways leading to MAP kinase activation by GH are poorly understood but appear to involve Grb2 and Shc. We now show that GH stimulated tyrosine phosphorylation of epidermal growth factor receptor (EGFR) and its association with Grb2, and concomitantly stimulated MAP kinase activity in liver, a major target tissue. Expression of EGFR and its mutants into CHO-GH receptor (GHR) cells revealed that GH-induced full activation of MAP kinase and c-fos expression required tyrosine phosphorylation sites of EGFR but not its intrinsic tyrosine kinase activity. Moreover, by also using dominant negative JAK2 and in vitro kinase assay, we demonstrated that tyrosine 1068 of EGFR was evidently one of the major phosphorylation and Grb2 binding sites stimulated by GH via JAK2. These data suggest that the role of EGFR in GH signalling is to be phosphorylated by JAK2, thereby providing docking sites for Grb2 and activating MAP kinases and gene expression. This novel cross talk pathway may provide the first example of the hormone and cytokine receptor superfamily transducing signals via associated nonreceptor tyrosine kinase by phosphorylating growth factor receptor and utilizing it as a docking protein independent of its receptor tyrosine kinase activity.
GH Mainly
Stimulates Tyrosine
Phosphorylation of EGFR and Its Association with Grb2 in Liver In Vivo
In order to study GH's intracellular signalling pathways, we looked at tyrosine phosphorylation of cellular proteins in response to GH in mouse et aI.
liver, a major target tissue, in vivo. Insulin receptor substrate (IRS)-1/IRS-2 have been reported to be tyrosine phosphorylated in response to GH in cultured cells such as primary rat adipocytes, 3T3-F442A fibroblasts and CHO-GHR cells [1] [2] [3] . GH-dependent tyrosyl phosphorylation of a protein with an Mr 180 kDa (pp 180) was prominently detected besides JAK2 and GH receptor, and its maximal tyrosine phosphorylation was roughly equivalent to the level of IRS-1 with an Mr 170 kDa observed following treatment with insulin [4] . With specific antibodies we found GH was able to induce tyrosine phosphorylation of IRS-1/IRS-2 in liver, albeit to a much lesser extent than that stimulated with insulin (unpublished data). Thus the identity of the pp180, the major tyrosinephosphorylated protein in response to GH, is not IRS-1 /IRS-2. GH stimulated association of pp180 with Grb2 but not with p85 P13-kinase. In addition, we could not extract pp180 without detergent, and it bound to WGA beads (data not shown). Therefore we tested whether EGFR is a candidate for pp180. We found that GH stimulated tyrosine phosphorylation of EGFR, but insulin did not. Moreover, immunodepletion of EGFR with specific antibody revealed that pp180 was almost entirely accounted for as EGFR [4] .
EGFR was tyrosine phosphorylated in a timeand dose-dependent manner in response to GH in liver in vivo. In addition, EGFR was found to be associated with Grb2 in response to GH. Shc was also tyrosine phosphorylated in response to GH, so that these data suggest that EGFR and Shc may constitute two major pathways for GH to activate MAP kinase, presumably through Grb2 [4]. To define the roles of GH-induced tyrosine phosphorylation of EGFR in biological effects of GH, we studied GH-induced c f os expression. Full induction of c-f os by GH has been reported to require several regulatory elements in the promoter including c-sis-inducible elements (STAT1 and 3 binding elements) and a ternary complex factor (TCF) element [7] . Maximal transcriptional activities of both STAT proteins [8] and TCF [9] were reported to require MAP kinases. As expected, in CHO-GHR cells expressing WT-or KN-EGFR, GH significantly stimulated c-fos expression as compared with those expressing LacZ of GHR [10] [11] [12] [13] . We therefore next examined whether GH-induced tyrosine phosphorylation of EGFR is dependent on JAK2 by using COS cells, in which the level of expression of JAK2 appears to be low enough for some level of coexpression of WT-JAK2 and GHR to be required in order to detect activation of JAK2 by GH [10] . Neither expression of GHR alone nor coexpression of kinase-inactive JAK2 and GHR, but coexpression of WT-JAK2 and GHR resulted in GHinduced tyrosine phosphorylation of EGFR (data not shown).
Furthermore, expression of AJAK2, which inhibits autophosphorylation of WT-JAK2 in a dominant negative manner [14] , almost completely abolished GH-induced tyrosine phosphorylation of EGFR in CHO-GHR transiently transfected with WT-EGFR. These data suggested that JAK2 kinase activity was required for tyrosine phosphorylation of EGFR in response to GH.
EGFR Could be Directly Phosphorylated by JAK2 In Vitro
After GH binding to its receptor, the affinity of JAK2 for GHR appears to increase [15] . To determine whether EGFR could be directly phosphorylated by JAK2, we carried out the immune complex kinase assays in vitro. The GSTcytoplasmic region of WT-EGFR was phosphorylated by JAK2 immunoisolated from CHO-GHR cell extracts treated with GH and it was able to associate with Grb2. Tyrosine 1068 of EGFR is a major binding site for Grb2, when stimulated with EGF [6, 16] . The amounts of JAK2-induced phosphorylation of the GST-cytoplasmic region of the quadruple point mutant retaining one tyrosine at 1068 among five main tyrosine autophosphorylation sites (F4/Y1068) and its association with Grb2 were approximately 70 to 80% of those of GST-WT-EGFR, whereas those of F5-EGFR were almost undetectable.
Indeed, F4/ Y1068 mutant EGFR was tyrosine phosphorylated and was capable of recruiting Grb2 to almost the same extent as WT-EGFR in response to GH in CHO-GHR cells. These data suggested that tyrosine 1068 may be one of the major phosphorylation and Grb2 binding sites induced by JAK2 in response to GH in vivo, but the possibility that other tyrosine phosphorylation sites may also be capable of mediating association with Grb2 cannot be excluded [6, 16] .
Discussion
Taken together, these data suggest that the role of EGFR in GH signalling is to be phosphorylated by JAK2, thereby providing docking sites for Grb2 and activating MAP kinase cascade and gene expression, independent of intrinsic tyrosine kinase of EGFR.
Studies with transgenic mice overexpressing GH or IGF-1 have led to the hypothesis that GH is a major direct regulator of postnatal liver growth [17] . DNA synthesis in 13-cells has been reported to be stimulated with GH or PRL [18] . In these contexts, reduced postnatal growth of hepatocytes and 13-cells seen in EGFR deficient mice [19] [20] [21] may be explained, at least in part, by abrogation of GH-induced MAP kinase activation via EGFR. In another tissue, the mammary gland of the waved-2 mice, which has a point mutation in the cytoplasmic domain of EGFR but not at the ATP binding site, lactation was impaired [22] . Thus one possible explanation from our data is that waved-2 mutation may interfere with the interactions between lactogenic hormones such as GH and PRL and EGFR signalling pathways. EGF-R has been reported to play a key role in UV [23] and G-protein-coupled receptors [24] signalling pathways. These reports claimed that intrinsic kinase activity of EGFR was required for their signal transduction.
More recently, however, it has been suggested that G-protein coupled receptors cause phosphorylation of EGFR independent of EGFR intrinsic kinase activity via Src kinase [25] . Our findings, together with these above observations on G-protein coupled receptors signalling, lead to the novel concept that nontyrosine kinase receptors transduce signals via associated nonreceptor tyrosine kinase by phosphorylating growth factor receptor and utilizing it as a docking protein independent of its receptor tyrosine kinase activity (Fig. 1) 
